Polymyxin B2 Sulfate presents a cyclic-linear lipopeptide architecture enriched with basic residues that support lipid-binding studies. Its amphipathic character drives solvent-dependent conformational changes. Researchers examine charge-driven interactions with membrane mimetics. Applications include structural biology, peptide-material exploration, and sequence-activity correlation.
CAT No: R2718
CAS No:108965-69-1
Synonyms/Alias:UNII-WTC2W6JDTU;WTC2W6JDTU;108965-69-1;Polymyxin B2 (sulfate);Q27292833;N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide;sulfuric acid;
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.